(Q37778598)

23 August 2017

1 reference

title

Pulmonary hypertension in chronic neonatal lung disease (English)

1 reference

23 August 2017

main subject

arterial hypertension

0 references

pulmonary hypertension

1 reference

Michael Farquhar

1

1 reference

23 August 2017

Dominic A. Fitzgerald

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692628

18 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20692628

18 June 2024

publication date

15 July 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S1526054210000370?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

https://api.elsevier.com/content/article/PII:S1526054210000370?httpAccept=text/plain

18 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Paediatric Respiratory Reviews

18 June 2024

published in

1 reference

23 August 2017

volume

11

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

149-153

1 reference

Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002.

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

A rational approach to home oxygen use in infants and children.

18 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Mechanisms initiating lung injury in the preterm

18 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Subclinical persisting pulmonary hypertension in chronic neonatal lung disease

18 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury.

18 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Statement on the care of the child with chronic lung disease of infancy and childhood

18 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era

18 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia

18 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Changes in pulmonary circulation in severe bronchopulmonary dysplasia

18 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

The management of pulmonary hypertension in children

18 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease

18 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients

18 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Right heart pressure determination by Doppler in infants with tricuspid regurgitation

18 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Doppler assessment of pulmonary artery pressure during recovery from hyaline membrane disease

18 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Doppler assessment of pulmonary artery pressure and extrapulmonary shunting in the acute phase of hyaline membrane disease

18 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Doppler echocardiographic prediction of pulmonary arterial hypertension in congenital heart disease

18 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Management of infants with bronchopulmonary dysplasia in North America

18 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Hypoxic airway constriction in infants of very low birth weight recovering from moderate to severe bronchopulmonary dysplasia

18 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Pathophysiology of pulmonary hypertension due to lung disease

18 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Recent advances in the pathogenesis and treatment of persistent pulmonary hypertension of the newborn

18 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

The dysmorphic pulmonary circulation in bronchopulmonary dysplasia: a growing story

18 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Oxygen-saturation targets and outcomes in extremely preterm infants.

18 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

BTS guidelines for home oxygen in children.

18 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Sleep apnea and hypoxemia in recently weaned premature infants with and without bronchopulmonary dysplasia.

18 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Higher SaO2 in chronic neonatal lung disease: does it improve sleep?

18 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Left ventricular diastolic dysfunction in bronchopulmonary dysplasia

18 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Monitoring cardiovascular function in infants with chronic lung disease of prematurity

18 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Oxygen therapy for infants with chronic lung disease

18 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Changes in pulmonary arterial pressure in preterm infants with chronic lung disease

18 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Quantifying pulmonary hypertension in ventilated infants with bronchiolitis: a pilot study

18 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Epidemiology and pathophysiology of apnoea of prematurity

18 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies

18 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide

18 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

18 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Hypoxia-induced pulmonary hypertension: Different impact of iloprost, sildenafil, and nitric oxide

18 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study

18 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Safety and efficacy of Sildenafil therapy in children with pulmonary hypertension

18 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Bosentan: in pediatric patients with pulmonary arterial hypertension

18 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Endothelin receptor antagonists for pulmonary arterial hypertension: rationale and place in therapy

18 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension

18 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Addition of sildenafil in patients with pulmonary arterial hypertension with inadequate response to bosentan monotherapy

18 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Preventing RSV bronchiolitis in vulnerable infants: the role of palivizumab

18 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

Reduced exercise capacity in children born very preterm.

18 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.PRRV.2010.05.001

18 June 2024

Identifiers

1 reference

23 August 2017

1 reference